Human cytomegalovirus infection and colorectal cancer risk: A meta-analysis

Oncotarget

Volumn 7, Issue 47, 2016, Pages 76735-76742

  Bai, Bingjun ^a,b   Wang, Xingxing ^a,b   Chen, Engeng ^a,b   Zhu, Hongbo ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b Key Laboratory of Biotherapy of Zhejiang Province   (China)

Author keywords

Colorectal cancer; HCMV; Meta analysis; Tumor progression; Viral DNA

Indexed keywords

ARTICLE; BRAZIL; CANCER GROWTH; CANCER PROGNOSIS; CANCER RISK; CARCINOGENESIS; CELL DIFFERENTIATION; COLORECTAL CANCER; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; GERMANY; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IRAN; ITALY; PREVALENCE; SWEDEN; TAIWAN; UNITED STATES; VIET NAM; CANCER GRADING; CANCER STAGING; COLORECTAL TUMOR; COMPLICATION; CYTOMEGALOVIRUS; META ANALYSIS; ODDS RATIO; PATHOLOGY; RISK; VIROLOGY;

COLORECTAL NEOPLASMS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; NEOPLASM GRADING; NEOPLASM STAGING; ODDS RATIO; PREVALENCE; RISK;

EID: 84998694374     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.12523     Document Type: Article

References (38)

1. Mattes FM, McLaughlin JE, Emery VC, Clark DA, Griffiths PD. Histopathological detection of owl's eye inclusions is still specific for cytomegalovirus in the era of human herpesviruses 6 and 7. J Clin Pathol. 2000; 53:612-614.
2. Fulop T, Larbi A, Pawelec G. Human t cell aging and the impact of persistent viral infections. Front Immunol 2013; 4:271.
3. Richardson AK, Currie MJ, Robinson BA, Morrin H, Phung Y, Pearson JF, Anderson TP, Potter JD, Walker LC. Cytomegalovirus and epstein-barr virus in breast cancer. Plos One. 2015; 10:e118989.
4. Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, Nabors LB, Cobbs CG, Britt WJ. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res. 2002; 62:3347-3350.
5. Giraldo G, Beth E, Huang ES: Kaposi's sarcoma and its relationship to cytomegalovirus (cmnv). Iii. Cmv dna and cmv early antigens in kaposi's sarcoma. Int J Cancer. 1980; 26:23-29.
6. Pacsa AS, Kummerlander L, Pejtsik B, Pali K. Herpesvirus antibodies and antigens in patients with cervical anaplasia and in controls. J Natl Cancer Inst. 1975; 55:775-781.
7. Geder KM, Lausch R, O'Neill F, Rapp F. Oncogenic transformation of human embryo lung cells by human cytomegalovirus. Science. 1976; 192:1134-1137.
8. Galloway DA, McDougall JK. The oncogenic potential of herpes simplex viruses: evidence for a 'hit-and-run' mechanism. Nature. 1983; 302:21-24.
9. Cinatl JJ, Cinatl J, Vogel JU, Rabenau H, Kornhuber B, Doerr HW. Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells. Intervirology. 1996; 39:259-269.
10. Cinatl J, Scholz M, Kotchetkov R, Vogel JU, Doerr HW. Molecular mechanisms of the modulatory effects of hcmv infection in tumor cell biology. Trends Mol Med. 2004; 10:19-23.
11. Michaelis M, Doerr HW, Cinatl J. The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia. 2009; 11:1-9.
12. Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B, Starling N. Colorectal cancer. Lancet. 2010; 375:1030-1047.
13. Watson AJ, Collins PD. Colon cancer: a civilization disorder. Dig Dis. 2011; 29:222-228.
14. Huang ES, Roche JK. Cytomegalovirus d.n.a. And adenocarcinoma of the colon: evidence for latent viral infection. LANCET 1978; 1:957-960.
15. Chen H, Jiang J, Chen C, Chou T, Chen Y, Chang Y, Lin S, Chan C, Yang C, Lin C, Lin J, Cho W, Chan Y. Human cytomegalovirus preferentially infects the neoplastic epithelium of colorectal cancer: a quantitative and histological analysis. J Clin Virol. 2012; 54:240-244.
16. Dimberg J, Hong TT, Skarstedt M, Lofgren S, Zar N, Matussek A. Detection of cytomegalovirus dna in colorectal tissue from swedish and vietnamese patients with colorectal cancer. Anticancer Res. 2013; 33:4947-4950.
17. Chen HP, Jiang JK, Lai PY, Chen CY, Chou TY, Chen YC, Chan CH, Lin SF, Yang CY, Chen CY, Lin CH, Lin JK, Ho DM, et al. Tumoral presence of human cytomegalovirus is associated with shorter disease-free survival in elderly patients with colorectal cancer and higher levels of intratumoral interleukin-17. Clin Microbiol Infect. 2014; 20:664-671.
18. Hart H, Neill WA, Norval M. Lack of association of cytomegalovirus with adenocarcinoma of the colon. Gut. 1982; 23:21-30.
19. Knösel T, Schewe C, Dietel M, Petersen I. Cytomegalovirus is not associated with progression and metastasis of colorectal cancer. Cancer Lett. 2004; 211:243-247.
20. Tafvizi F, Fard ZT. Detection of human cytomegalovirus in patients with colorectal cancer by nested-pcr. Asian Pac J Cancer P. 2014; 15:1453-1457.
21. Chen HP, Jiang JK, Lai PY, Teo WH, Yang CY, Chou TY, Lin CH, Chan YJ. The serologic and viraemic status of human cytomegalovirus infection in patients with colorectal cancer is not correlated with viral replication and transcription in tumours. J Gen Virol. 2015.
22. Chen HP, Jiang JK, Chan CH, Teo WH, Yang CY, Chen YC, Chou TY, Lin CH, Chan YJ. Genetic polymorphisms of the human cytomegalovirus ul144 gene in colorectal cancer and its association with clinical outcome. J Gen Virol. 2015.
23. Bender C, Zipeto D, Bidoia C, Costantini S, Zamo A, Menestrina F, Bertazzoni U. Analysis of colorectal cancers for human cytomegalovirus presence. Infect Agent Cancer 2009; 4:6.
24. Mariguela VC, Chacha SG, Cunha AA, Troncon LE, Zucoloto S, Figueiredo LT. Cytomegalovirus in colorectal cancer and idiopathic ulcerative colitis. Rev Inst Med Trop Sao Paulo 2008; 50:83-87.
25. Akintola-Ogunremi O, Luo Q, He TC, Wang HL: Is cytomegalovirus associated with human colorectal tumorigenesis? Am J Clin Pathol. 2005; 123:244-249.
26. Sandford GR, Schumacher U, Ettinger J, Brune W, Hayward GS, Burns WH, Voigt S. Deletion of the rat cytomegalovirus immediate-early 1 gene results in a virus capable of establishing latency, but with lower levels of acute virus replication and latency that compromise reactivation efficiency. J Gen Virol. 2010; 91:616-621.
27. Penkert RR, Kalejta RF. Nuclear localization of tegumentdelivered pp71 in human cytomegalovirus-infected cells is facilitated by one or more factors present in terminally differentiated fibroblasts. J Virol. 2010; 84:9853-9863.
28. Rogers BB, Alpert LC, Hine EA, Buffone GJ. Analysis of dna in fresh and fixed tissue by the polymerase chain reaction. Am J Pathol. 1990; 136:541-548.
29. Koshiba M, Ogawa K, Hamazaki S, Sugiyama T, Ogawa O, Kitajima T. The effect of formalin fixation on dna and the extraction of high-molecular-weight dna from fixed and embedded tissues. Pathol Res Pract. 1993; 189:66-72.
30. Jansen MA, van den Heuvel D, Bouthoorn SH, Jaddoe VW, Hooijkaas H, Raat H, Fraaij PL, van Zelm MC, Moll HA. Determinants of ethnic differences in cytomegalovirus, epstein-barr virus, and herpes simplex virus type 1 seroprevalence in childhood. J Pediatr. 2016; 170:126-134.
31. Lantos PM, Permar SR, Hoffman K, Swamy GK. The excess burden of cytomegalovirus in african american communities: a geospatial analysis. Open Forum Infect Dis. 2015; 2:v180.
32. Merika E, Saif MW, Katz A, Syrigos K, Morse M: Review. Colon cancer vaccines: an update. In Vivo. 2010; 24:607-628.
33. Zahir MN, Azhar EM, Rafiq S, Ghias K, Shabbir-Moosajee M. Clinical features and outcome of sporadic colorectal carcinoma in young patients: a cross-sectional analysis from a developing country. Isrn Oncol. 2014; 2014:461570.
34. Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, Ganiats T, Levin T, Woolf S, Johnson D, Kirk L, Litin S, Simmang C. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology0. 2003; 124:544-560.
35. Scheurer ME, Bondy ML, Aldape KD, Albrecht T, El-Zein R. Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathol. 2008; 116:79-86.
36. Cai Z, Xu J, Zhou Y, Zheng J, Lin K, Zheng S, Ye M, He Y, Liu C, Xue Z. Human cytomegalovirus-encoded us28 may act as a tumor promoter in colorectal cancer. World J Gastroentero. 2016; 22:2789.
37. Michaelis M, Doerr HW, Cinatl J. The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia. 2009; 11:1-9.
38. Prins RM, Cloughesy TF, Liau LM. Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate. N Engl J Med. 2008; 359:539-541.